Loading...
Modification of the Early Gene Enhancer-promoter Improves the Oncolytic Potency of Adenovirus 11
Oncolytic adenoviruses based on serotype 5 (Ad5) have several shortcomings, including the downregulation of its receptor in cancer cells, high prevalence of neutralizing antibodies and hepatotoxicity. Another adenoviral serotype, Ad11, could overcome these obstacles. Here, we show that human cancer...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3272483/ https://ncbi.nlm.nih.gov/pubmed/22086234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.242 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|